Репозиторий Dspace

Novel Benzothiazole-Based Ureas as 17 beta-HSD10 Inhibitors, A Potential Alzheimer's Disease Treatment

Показать сокращенную информацию

dc.contributor.author Aitken, Laura cze
dc.contributor.author Benek, Ondřej cze
dc.contributor.author McKelvie, Brogan E. cze
dc.contributor.author Hughes, Rebecca E. cze
dc.contributor.author Hroch, Lukas cze
dc.contributor.author Schmidt, Monika cze
dc.contributor.author Major, Louise L. cze
dc.contributor.author Vinklářová, Lucie cze
dc.contributor.author Kuča, Kamil cze
dc.contributor.author Smith, Terry K. cze
dc.contributor.author Musílek, Kamil cze
dc.contributor.author Gunn-Moore, Frank J. cze
dc.date.accessioned 2019-10-17T07:27:59Z
dc.date.available 2019-10-17T07:27:59Z
dc.date.issued 2019 eng
dc.identifier.issn 1420-3049 eng
dc.identifier.uri http://hdl.handle.net/20.500.12603/58
dc.description.abstract It has long been established that mitochondrial dysfunction in Alzheimer's disease (AD) patients can trigger pathological changes in cell metabolism by altering metabolic enzymes such as the mitochondrial 17 beta-hydroxysteroid dehydrogenase type 10 (17 beta-HSD10), also known as amyloid-binding alcohol dehydrogenase (ABAD). We and others have shown that frentizole and riluzole derivatives can inhibit 17 beta-HSD10 and that this inhibition is beneficial and holds therapeutic merit for the treatment of AD. Here we evaluate several novel series based on benzothiazolylurea scaffold evaluating key structural and activity relationships required for the inhibition of 17 beta-HSD10. Results show that the most promising of these compounds have markedly increased potency on our previously published inhibitors, with the most promising exhibiting advantageous features like low cytotoxicity and target engagement in living cells. eng
dc.format p. 1-23 eng
dc.language.iso eng eng
dc.publisher MDPI-Molecular diversity preservation international eng
dc.relation.ispartof Molecules, volume 24, issue: 15 eng
dc.rights Pouze v rámci univerzity eng
dc.subject Alzheimer's disease (AD) eng
dc.subject amyloid-beta peptide (A beta) eng
dc.subject mitochondria eng
dc.subject 17 beta-hydroxysteroid dehydrogenase type 10 (17 beta-HSD10) eng
dc.subject amyloid binding alcohol dehydrogenase (ABAD) eng
dc.subject benzothiazole eng
dc.subject 192/5000 Alzheimerova choroba (AD) cze
dc.subject amyloid-beta peptid (A beta) cze
dc.subject mitochondrie cze
dc.subject 17 beta-hydroxysteroid dehydrogenázy typu 10 (17 beta-HSD10) cze
dc.subject alkohol dehydrogenáza vázající amyloid (ABAD) cze
dc.subject benzothiazol cze
dc.title Novel Benzothiazole-Based Ureas as 17 beta-HSD10 Inhibitors, A Potential Alzheimer's Disease Treatment eng
dc.title.alternative 104/5000 Nové inhibitory močovin na bázi benzothiazolu Inc. 17 inhibitory beta-HSD10, potenciální léčba Alzheimerovy choroby cze
dc.type article eng
dc.identifier.obd 43875319 eng
dc.identifier.wos 000482441100080 eng
dc.identifier.doi 10.3390/molecules24152757 eng
dc.description.abstract-translated It has long been established that mitochondrial dysfunction in Alzheimer's disease (AD) patients can trigger pathological changes in cell metabolism by altering metabolic enzymes such as the mitochondrial 17 beta-hydroxysteroid dehydrogenase type 10 (17 beta-HSD10), also known as amyloid-binding alcohol dehydrogenase (ABAD). We and others have shown that frentizole and riluzole derivatives can inhibit 17 beta-HSD10 and that this inhibition is beneficial and holds therapeutic merit for the treatment of AD. Here we evaluate several novel series based on benzothiazolylurea scaffold evaluating key structural and activity relationships required for the inhibition of 17 beta-HSD10. Results show that the most promising of these compounds have markedly increased potency on our previously published inhibitors, with the most promising exhibiting advantageous features like low cytotoxicity and target engagement in living cells. cze
dc.publicationstatus postprint eng
dc.peerreviewed yes eng
dc.note Article Number: 2757 eng


Файлы в этом документе

Данный элемент включен в следующие коллекции

Показать сокращенную информацию

Поиск в DSpace


Просмотр

Моя учетная запись